-- 根據週二提交給孟買證券交易所（BSE）的文件顯示，Auro Laboratories（BOM:530233）已收到歐洲藥品品質管理局（EDQM）對其鹽酸二甲雙胍CEP文件的檢驗認證。 該公司股價在周三的交易中上漲了近4%。 文件稱，該認證確認其位於MIDC Tarapur的工廠符合歐盟良好生產規範（GMP）的要求。
Related Articles
Mining & Metals
Earnings Flash (SDE.TO) Spartan Delta Corp. Increased 2026 Guidance and Increase To Credit Facility
$SDE.TO
Asia
ValueMax Raises SG$24 Million Through Digital Securities Issuance
ValueMax (SGX:T6I) raised over SG$23.9 million through the issuance of digital securities on the SDXX platform, according to a Wednesday filing with the Singapore Exchange.The issuance will be listed on the SDXX platform on May 7, the filing added.
$SGX:T6I
Mining & Metals
Earnings Flash (ADEN.TO) ADENTRA Posted Q1 Adjusted EPS US$0.38 per Share, vs. FactSet Est of $0.31
$ADEN.TO